Table 1B.
Baseline (T1) | Follow up (T2) | Wilcoxon | |||||||
---|---|---|---|---|---|---|---|---|---|
Mean | SD | Min | Max | Mean | SD | Min | Max | Z/p | |
Pro-inflammatory | |||||||||
IL-2 [pg/mL] | 7.16 | 7.11 | 0.00 | 25.96 | 5.76 | 5.62 | 0.00 | 18.19 | −1.885/0.059 |
IL-12 [pg/mL] | 10.33 | 8.33 | 0.00 | 40.90 | 8.79 | 6.79 | 0.00 | 31.96 | −2.072/0.038 |
GM-CSF [pg/mL] | 38.03 | 20.91 | 3.83 | 97.78 | 35.02 | 16.05 | 9.10 | 65.55 | −1.323/0.186 |
IFN-γ [pg/mL] | 121.19 | 64.64 | 0.00 | 280.09 | 112.85 | 57.15 | 19.44 | 269.73 | −1.169/0.242 |
TNF-α [pg/mL] | 31.19 | 18.73 | 3.71 | 84.87 | 28.21 | 14.78 | 6.34 | 64.95 | −1.323/0.186 |
Anti-inflammatory | |||||||||
IL-4 [pg/mL] | 4.56 | 2.57 | 0.09 | 10.32 | 4.13 | 2.10 | 0.79 | 9.84 | −1.263/0.206 |
IL-10 [pg/mL] | 4.02 | 3.09 | 0.00 | 18.03 | 3.60 | 3.79 | 0.00 | 18.22 | −0.850/0.395 |
IL-5 [pg/mL] | 3.02 | 2.53 | 0.00 | 13.10 | 2.56 | 1.62 | 0.00 | 6.87 | −1.550/0.121 |
IL-13 [pg/mL] | 5.55 | 4.98 | 0.00 | 18.16 | 4.59 | 3.87 | 0.00 | 13.90 | −1.707/0.088 |
In bold: p > 0.05.